Comparative costs of gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of non-small cell lung cancer in Germany

被引：0
|
作者：
Bischoff, H
Hamann, M
Stynes, G
Bhalla, S
Tilden, D
Kielhorn, A
机构：
[1] Stabsstelle Med Management, Heidelberg, Germany
[2] Eli Lilly Germany, Bad Homburg, Germany
[3] M TAG Ltd, Hammersmith, England
[4] Eli Lilly, Windlesham, Surrey, England
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65750-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of Endostar combined with vinorelbine and cisplatin for the treatment of advanced non-small cell lung cancer: a comparative study
    Guo, Jun-Cheng
    Yang, Yi-Jun
    Guo, Min
    Jiang Xiang-Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 6062 - 6069
  • [42] Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer
    Ramsey, SD
    Moinpour, CM
    Lovato, LC
    Crowley, JJ
    Grevstad, P
    Presant, CA
    Rivkin, SE
    Kelly, K
    Gandara, DR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (04) : 291 - 297
  • [43] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    Javier Castro de Carpeño
    M. González Barón
    J. Aguiar
    J. I. Chacón
    J. Feliu
    M. J. García
    C. Madroñal
    A. Colmenarejo
    J. J. Sánchez
    A. Ordóñez
    Cancer Chemotherapy and Pharmacology, 2006, 58
  • [44] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    de Carpeño, JC
    Barón, MG
    Aguiar, J
    Chacón, JI
    Feliu, J
    García, MJ
    Madroñal, C
    Colmenarejo, A
    Sánchez, JJ
    Ordóñez, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 266 - 271
  • [45] Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer
    Sorensen, JB
    Stenbygaard, LE
    Dombernowsky, P
    Hansen, HH
    ANNALS OF ONCOLOGY, 1999, 10 (09) : 1043 - 1049
  • [46] A cost analysis of treatment with bevacizumab plus cisplatin and gemcitabine (BCG) versus cetuximab plus vinorelbine and cisplatin (CVC) in patients with advanced or recurrent non-small cell lung cancer (NSCLC) in Germany
    Heigener, D. F.
    Wiesner, C.
    Aultman, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Cisplatin or carboplatin for the treatment of non-small cell lung cancer: do they have equivalent efficacy?
    Berghmans, T
    Paesmans, M
    Sculier, JP
    LUNG CANCER, 2001, 34 (01) : 15 - 17
  • [48] A comparative study of combination chemotherapy with docetaxel/cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
    El-Nashar, E
    LUNG CANCER, 2005, 49 : S243 - S243
  • [49] Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer
    Cortes, J
    Rodriguez, J
    Calvo, E
    Gurpide, A
    Garcia-Foncillas, J
    Salgado, E
    Aramendia, JM
    Lopez-Picazo, JM
    Hernandez, B
    Hidalgo, R
    Aristu, JJ
    Brugarolas, A
    Martin-Algarra, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 299 - 303
  • [50] Chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer in elderly patients
    Miron, L
    Clement, D
    Marinca, M
    LUNG CANCER, 2005, 49 : S258 - S259
12345